![Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action](https://www.cgdev.org/sites/default/files/2022-12/covid-antiviral-note-card.jpeg)
Oral Antiviral Treatments for COVID-19: Time to Revisit? | Center For Global Development | Ideas to Action
![Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile](https://uchile.cl/dam/jcr:5e5708dd-208a-4472-8aec-5ca96e84328d/DESTACADO-MARIOCHIONG-LUN-161221.png)
Prof. Mario Chiong opina sobre antiviral contra el Coronavirus de Pfizer en diario Las Ultimas Noticias - Universidad de Chile
![White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis](https://www.thewellnews.com/wp-content/uploads/2022/04/covid.jpg)
White House Focuses Efforts on Increasing Supply of Paxlovid | The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis
![People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe](https://www.bostonglobe.com/resizer/XmmyGGA5Kf6LNyILRkKD5KabQbw=/arc-anglerfish-arc2-prod-bostonglobe/public/PKDKBNJ4W7M4AS7ATBJNZ6USXA.jpg)
People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe
![A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health](https://speakingofmedicine.plos.org/wp-content/uploads/sites/14/2022/05/Figure.jpeg)
A strategy that gives half of the world a discount on COVID-19 antivirals, but keeps a firm grip on power - Speaking of Medicine and Health
![James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X](https://pbs.twimg.com/media/FIb0zj0X0AU6fgE.png)
James Packard Love on X: "Chile NGO files for compulsory license on Paxlovid patents. @innovarteorg https://t.co/DBMppfqrP7" / X
![People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe](https://www.bostonglobe.com/resizer/TATClwdDgaNNaIYiYzXrtgxY71I=/arc-anglerfish-arc2-prod-bostonglobe/public/DWMH3NIHXOFICJ75UZIYV2RCTI.jpg)
People who rebound with COVID-19 after Paxlovid may be highly contagious, new studies suggest - The Boston Globe
![078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx 078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx](https://www.gob.mx/cms/uploads/press/main_image/235280/post__com_078_imagen.jpg)
078. Insabi inicia entrega de medicamento Paxlovid para tratar a pacientes con COVID grave | Instituto de Salud para el Bienestar | Gobierno | gob.mx
![Requerimiento al Ministerio de Salud de Chile para la declaración de existencia de razones de salud pública para el otorgamiento de una licencia obligatoria del medicamento Paxlovid para el tratamiento de Covid Requerimiento al Ministerio de Salud de Chile para la declaración de existencia de razones de salud pública para el otorgamiento de una licencia obligatoria del medicamento Paxlovid para el tratamiento de Covid](https://www.corporacioninnovarte.org/wp-content/uploads/2022/09/POST-PFIZER02_Artboard-7-scaled.jpg)
Requerimiento al Ministerio de Salud de Chile para la declaración de existencia de razones de salud pública para el otorgamiento de una licencia obligatoria del medicamento Paxlovid para el tratamiento de Covid
![Presidente de la Comisión de Salud de la Cámara de Diputados de Chile Dr. Tomás Lagomarsino, recomienda uso de Paxlovid. | INNOVARTE ONG Presidente de la Comisión de Salud de la Cámara de Diputados de Chile Dr. Tomás Lagomarsino, recomienda uso de Paxlovid. | INNOVARTE ONG](https://www.corporacioninnovarte.org/wp-content/uploads/2022/11/Diputado-scaled.jpg)